The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.


Journal

The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003

Informations de publication

Date de publication:
05 2020
Historique:
received: 09 03 2020
revised: 16 03 2020
accepted: 18 03 2020
pubmed: 30 3 2020
medline: 14 5 2020
entrez: 30 3 2020
Statut: ppublish

Résumé

In December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, emerged in Wuhan, China. Since then, the city of Wuhan has taken unprecedented measures in response to the outbreak, including extended school and workplace closures. We aimed to estimate the effects of physical distancing measures on the progression of the COVID-19 epidemic, hoping to provide some insights for the rest of the world. To examine how changes in population mixing have affected outbreak progression in Wuhan, we used synthetic location-specific contact patterns in Wuhan and adapted these in the presence of school closures, extended workplace closures, and a reduction in mixing in the general community. Using these matrices and the latest estimates of the epidemiological parameters of the Wuhan outbreak, we simulated the ongoing trajectory of an outbreak in Wuhan using an age-structured susceptible-exposed-infected-removed (SEIR) model for several physical distancing measures. We fitted the latest estimates of epidemic parameters from a transmission model to data on local and internationally exported cases from Wuhan in an age-structured epidemic framework and investigated the age distribution of cases. We also simulated lifting of the control measures by allowing people to return to work in a phased-in way and looked at the effects of returning to work at different stages of the underlying outbreak (at the beginning of March or April). Our projections show that physical distancing measures were most effective if the staggered return to work was at the beginning of April; this reduced the median number of infections by more than 92% (IQR 66-97) and 24% (13-90) in mid-2020 and end-2020, respectively. There are benefits to sustaining these measures until April in terms of delaying and reducing the height of the peak, median epidemic size at end-2020, and affording health-care systems more time to expand and respond. However, the modelled effects of physical distancing measures vary by the duration of infectiousness and the role school children have in the epidemic. Restrictions on activities in Wuhan, if maintained until April, would probably help to delay the epidemic peak. Our projections suggest that premature and sudden lifting of interventions could lead to an earlier secondary peak, which could be flattened by relaxing the interventions gradually. However, there are limitations to our analysis, including large uncertainties around estimates of R Bill & Melinda Gates Foundation, National Institute for Health Research, Wellcome Trust, and Health Data Research UK.

Sections du résumé

BACKGROUND
In December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, emerged in Wuhan, China. Since then, the city of Wuhan has taken unprecedented measures in response to the outbreak, including extended school and workplace closures. We aimed to estimate the effects of physical distancing measures on the progression of the COVID-19 epidemic, hoping to provide some insights for the rest of the world.
METHODS
To examine how changes in population mixing have affected outbreak progression in Wuhan, we used synthetic location-specific contact patterns in Wuhan and adapted these in the presence of school closures, extended workplace closures, and a reduction in mixing in the general community. Using these matrices and the latest estimates of the epidemiological parameters of the Wuhan outbreak, we simulated the ongoing trajectory of an outbreak in Wuhan using an age-structured susceptible-exposed-infected-removed (SEIR) model for several physical distancing measures. We fitted the latest estimates of epidemic parameters from a transmission model to data on local and internationally exported cases from Wuhan in an age-structured epidemic framework and investigated the age distribution of cases. We also simulated lifting of the control measures by allowing people to return to work in a phased-in way and looked at the effects of returning to work at different stages of the underlying outbreak (at the beginning of March or April).
FINDINGS
Our projections show that physical distancing measures were most effective if the staggered return to work was at the beginning of April; this reduced the median number of infections by more than 92% (IQR 66-97) and 24% (13-90) in mid-2020 and end-2020, respectively. There are benefits to sustaining these measures until April in terms of delaying and reducing the height of the peak, median epidemic size at end-2020, and affording health-care systems more time to expand and respond. However, the modelled effects of physical distancing measures vary by the duration of infectiousness and the role school children have in the epidemic.
INTERPRETATION
Restrictions on activities in Wuhan, if maintained until April, would probably help to delay the epidemic peak. Our projections suggest that premature and sudden lifting of interventions could lead to an earlier secondary peak, which could be flattened by relaxing the interventions gradually. However, there are limitations to our analysis, including large uncertainties around estimates of R
FUNDING
Bill & Melinda Gates Foundation, National Institute for Health Research, Wellcome Trust, and Health Data Research UK.

Identifiants

pubmed: 32220655
pii: S2468-2667(20)30073-6
doi: 10.1016/S2468-2667(20)30073-6
pmc: PMC7158905
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e261-e270

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208812/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206250/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 210758/Z/18/Z
Pays : United Kingdom

Investigateurs

Stefan Flasche (S)
Samuel Clifford (S)
Carl A B Pearson (CAB)
James D Munday (JD)
Sam Abbott (S)
Hamish Gibbs (H)
Alicia Rosello (A)
Billy J Quilty (BJ)
Thibaut Jombart (T)
Fiona Sun (F)
Charlie Diamond (C)
Amy Gimma (A)
Kevin van Zandvoort (K)
Sebastian Funk (S)
Christopher I Jarvis (CI)
W John Edmunds (WJ)
Nikos I Bosse (NI)
Joel Hellewell (J)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Lancet Infect Dis. 2020 May;20(5):e102-e107
pubmed: 32145768
Nature. 2004 May 13;429(6988):180-4
pubmed: 15141212
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
Proc Biol Sci. 2003 Apr 7;270(1516):699-708
pubmed: 12713743
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
BMC Med. 2011 Jul 19;9:87
pubmed: 21771290
Am J Med. 1987 Jun 19;82(6A):15-9
pubmed: 3591813
Nature. 2003 Oct 16;425(6959):681-5
pubmed: 14562094
Am J Epidemiol. 2006 Nov 15;164(10):936-44
pubmed: 16968863
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046816
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252
Emerg Infect Dis. 2020 May;26(5):976-984
pubmed: 32027585
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Science. 2003 Jun 20;300(5627):1961-6
pubmed: 12766206
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Infect Dis. 2003 Mar 1;187(5):785-90
pubmed: 12599052
Proc Biol Sci. 2009 Jul 7;276(1666):2469-76
pubmed: 19364743
Proc Biol Sci. 1997 Jul 22;264(1384):949-57
pubmed: 9263464
Trends Microbiol. 1999 Sep;7(9):372-7
pubmed: 10470046
BMC Infect Dis. 2009 Nov 27;9:187
pubmed: 19943919
J R Soc Interface. 2019 Aug 30;16(157):20190317
pubmed: 31387486
Sci Rep. 2019 Oct 22;9(1):15141
pubmed: 31641189
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
Lancet. 2020 Mar 7;395(10226):764-766
pubmed: 32105609
Ann Appl Stat. 2011;5(3):1816-1838
pubmed: 22427793
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
BMC Public Health. 2018 Apr 18;18(1):518
pubmed: 29669545
Wellcome Open Res. 2020 Feb 3;5:17
pubmed: 32322691

Auteurs

Kiesha Prem (K)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: kiesha.prem@lshtm.ac.uk.

Yang Liu (Y)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Timothy W Russell (TW)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Adam J Kucharski (AJ)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Rosalind M Eggo (RM)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Nicholas Davies (N)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Mark Jit (M)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Petra Klepac (P)

Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH